AAAAAA
Results:
1-14
|
Results: 14
Authors:
HALPERIN JA
Citation: Ja. Halperin, USEFUL PATIENT INFORMATION ON PRESCRIPTION DRUGS, The Annals of pharmacotherapy, 32(5), 1998, pp. 612-612
Authors:
HALPERIN JA
ACOSTA J
HETTINGA J
FLUCKIGER R
Citation: Ja. Halperin et al., A NOVEL ROLE FOR COMPLEMENT IN THE VASCULAR COMPLICATIONS OF DIABETES, Molecular immunology, 35(6-7), 1998, pp. 106-106
Authors:
AKTAS H
FLUCKIGER R
ACOSTA JA
SAVAGE JM
PALAKURTHI SS
HALPERIN JA
Citation: H. Aktas et al., DEPLETION OF INTRACELLULAR CA2-ALPHA, AND SUSTAINED INHIBITION OF TRANSLATION INITIATION MEDIATE THE ANTICANCER EFFECTS OF CLOTRIMAZOLE( STORES, PHOSPHORYLATION OF EIF2), Proceedings of the National Academy of Sciences of the United Statesof America, 95(14), 1998, pp. 8280-8285
Authors:
ACOSTA JA
HALPERIN JA
Citation: Ja. Acosta et Ja. Halperin, INHIBITION OF THE COMPLEMENT REGULATORY PROTEIN CD59 BY NONENZYMATIC GLYCATION - ITS POTENTIAL PATHOGENIC ROLE IN THE PROLIFERATIVE COMPLICATIONS OF DIABETES-MELLITUS, Journal of investigative medicine, 44(3), 1996, pp. 199-199
Authors:
ACOSTA JA
BENZAQUEN LR
GOLDSTEIN DJ
TOSTESON MT
HALPERIN JA
Citation: Ja. Acosta et al., THE TRANSIENT PORE FORMED BY HOMOLOGOUS TERMINAL COMPLEMENT COMPLEXESFUNCTIONS AS A BIDIRECTIONAL ROUTE FOR THE TRANSPORT OF AUTOCRINE ANDPARACRINE SIGNALS ACROSS HUMAN CELL-MEMBRANES, Molecular medicine, 2(6), 1996, pp. 755-765
Authors:
BENZAQUEN LR
BRUGNARA C
BYERS HR
GATTONICELLI S
HALPERIN JA
Citation: Lr. Benzaquen et al., CLOTRIMAZOLE INHIBITS CELL-PROLIFERATION IN-VITRO AND IN-VIVO, Nature medicine, 1(6), 1995, pp. 534-540
Authors:
HALPERIN JA
BRUGNARA C
Citation: Ja. Halperin et C. Brugnara, TREATING RHEUMATOID-ARTHRITIS WITH CLOTRIMAZOLE - REPLY, Nature medicine, 1(10), 1995, pp. 978-978
Authors:
HALPERIN JA
Citation: Ja. Halperin, MEDICINE, PHARMACY, AND INDUSTRY - A FLYS EYE VIEW OF HEALTH-CARE, The Annals of pharmacotherapy, 29(9), 1995, pp. 925-930
Authors:
SHEN Y
HALPERIN JA
LEE CM
Citation: Y. Shen et al., COMPLEMENT-MEDIATED NEUROTOXICITY IS REGULATED BY HOMOLOGOUS RESTRICTION, Brain research, 671(2), 1995, pp. 282-292
Authors:
BENZAQUEN LR
NICHOLSONWELLER A
HALPERIN JA
Citation: Lr. Benzaquen et al., TERMINAL COMPLEMENT PROTEINS C5B-9 RELEASE BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR FROM ENDOTHELIAL-CELLS, The Journal of experimental medicine, 179(3), 1994, pp. 985-992
Authors:
HALPERIN JA
Citation: Ja. Halperin, UNTITLED, Journal of the American Veterinary Medical Association, 205(2), 1994, pp. 192-194
Authors:
NICHOLSONWELLER A
HALPERIN JA
Citation: A. Nicholsonweller et Ja. Halperin, MEMBRANE SIGNALING BY COMPLEMENT C5B-9, THE MEMBRANE ATTACK COMPLEX, Immunologic research, 12(3), 1993, pp. 244-257
Authors:
HALPERIN JA
TARATUSKA A
NICHOLSONWELLER A
Citation: Ja. Halperin et al., TERMINAL COMPLEMENT COMPLEX C5B-9 STIMULATES MITOGENESIS IN 3T3 CELLS, The Journal of clinical investigation, 91(5), 1993, pp. 1974-1978
Authors:
BERGER HJ
TARATUSKA A
SMITH TW
HALPERIN JA
Citation: Hj. Berger et al., ACTIVATED COMPLEMENT DIRECTLY MODIFIES THE PERFORMANCE OF ISOLATED HEART-MUSCLE CELLS FROM GUINEA-PIG AND RAT, The American journal of physiology, 265(1), 1993, pp. 80000267-80000272
Risultati:
1-14
|